Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet . [electronic resource]
Producer: 20170619Description: 355-367 p. digitalISSN:- 0946-1965
- Administration, Oral
- Adult
- Area Under Curve
- Benzhydryl Compounds -- administration & dosage
- Biological Availability
- Cross-Over Studies
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Drug Combinations
- Female
- Germany
- Glucosides -- administration & dosage
- Healthy Volunteers
- Humans
- Hypoglycemic Agents -- administration & dosage
- Kidney Tubules, Proximal -- drug effects
- Linagliptin -- administration & dosage
- Male
- Metabolic Clearance Rate
- Middle Aged
- Sodium-Glucose Transporter 2 -- metabolism
- Sodium-Glucose Transporter 2 Inhibitors
- Solubility
- Tablets
- Therapeutic Equivalency
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.